DIRZILVED

Serial Number 99204031
688

Registration Progress

Application Filed
May 27, 2025
Under Examination
Sep 30, 2025
Approved for Publication
Aug 5, 2025
Published for Opposition
Aug 5, 2025
Registered

Trademark Image

DIRZILVED

Basic Information

Serial Number
99204031
Filing Date
May 27, 2025
Published for Opposition
August 5, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Sep 30, 2025
Application
Pending
Classes
005

Rights Holder

Merck Sharp & Dohme LLC

16
Address
126 East Lincoln Avenue
Rahway, NJ 07065

Ownership History

Merck Sharp & Dohme LLC

Original Applicant
16
Rahway, NJ

Merck Sharp & Dohme LLC

Owner at Publication
16
Rahway, NJ

Legal Representation

Attorney
Lisa M. Dellamura

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

9 events
Date Code Type Description Documents
Sep 30, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 5, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Aug 5, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 30, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 26, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 25, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
May 27, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 27, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Classification

International Classes
005